Skip to main content

Tag: recall

Coterie sour apple blunt recalled from Alberta

Written by Staff on . Posted in Cannabis News, Products, Quebec.

Quebec-based cannabis producer Culture Kizos Inc./Kizos Culture Inc. recalled one lot of its Coterie Double Infused Sour Apple Blunt Pre-rolls cannabis extract earlier this month.

On August 19, Health Canada listed a voluntary product recall for the one-gram pre-rolls due to microbial contamination for Lot L24135H packaged on May 14, 2025. This product was sold through authorized retailers in Alberta. 

Health Canada says the affected product does not meet certain microbial contaminant limits for bacteria as specified by the Good Production Practices requirements of the Cannabis Regulations. However, the probability of serious adverse health consequences is remote, adds the recall notice.  

As of August 19, Culture Kizos Inc./Kizos Culture Inc. and Health Canada say they have not received any complaints related to the recalled lot. Neither Culture Kizos Inc./Kizos Culture Inc. nor Health Canada have received any adverse reaction reports for the recalled cannabis product lot. 

There were 1,281 units of recalled product sold from June 9 to August 12, 2024.

Expanded recall notice for products with unlabelled cannabinoids

Written by Staff on . Posted in Cannabis News, Products.

Health Canada has issued a notice of an expanded recall it first issued in June for cannabis products containing an “undeclared intoxicating cannabinoid.”

The updated recall, issued on August 9, adds eight new lots to the voluntary recall, including two new product brands. The issue section in the recall has also been clarified.

In total, 14 lots of iNaturally Organic Inc’s Emprise CBN+CBD 50 mg Softgels, NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels, NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil, Ultra Plus 1200 mg MultiCannabinoid Oil and Ultra Plus 750 mg MultiCannabinoid Softgels cannabis extracts have now been recalled.

Inspection, testing, and sampling by Health Canada showed that each sample contained a significant quantity of the intoxicating cannabinoid hexahydrocannabinol (HHC) and of THC in products identified as containing more than three (3) mg per unit (for softgels) or g (for oils). 

The presence or quantity of HHC is not indicated on the label. HHC is considered a “semisynthetic CBD,” often synthesized from CBD.

The tests are also said to have shown significantly less cannabichromene (CBC) than identified on the licence holder’s certificate of analysis and/or product labels. 

In response to this testing, Alberta’s iNaturally Organic Inc. began a voluntary recall of the affected products that were sold in Ontario, British Columbia, Alberta, Manitoba, Saskatchewan, and the Yukon.

These products were also sold to medical clients through Rosebud Productions Inc. (Herbal Dispatch), Open Fields Winnipeg, Open Fields Saskatchewan, and Médicibis.

Health Canada says that consuming these products when alertness is required could pose “potentially serious adverse health consequences, such as when performing safety-sensitive activities like driving motor vehicles or operating heavy machinery.”  

To date, iNaturally Organic Inc. has received two adverse reaction reports about these products, and Health Canada has received five adverse reaction reports and one complaint related to these products.

There were 8,526 units of Emprise CBN+CBD 50 mg Softgels distributed, 2,286 units of NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil Softgels distributed, 2,534 units of NuLeaf Naturals 1800 mg Full Spectrum Hemp Multicannabinoid Oil distributed, 3,324 units of Ultra Plus 750 mg MultiCannabinoid Softgels distributed, and 600 units of Ultra Plus 1200 mg MultiCannabinoid Oil distributed.

The recalled products were sold from December 2022 to July 2024.

Health Canada says consumers can return the product to the retailer where it was purchased or dispose of it themselves. 

Incorrect labelling leads to recall for Canna Farms Tangerine Dream

Written by Staff on . Posted in Business, Cannabis News, Products.

Canna Farms has recalled one lot of its Tangerine Dream five gram dried cannabis sold through its medical sales channel for incorrect labelling as of August 2. 

The products were sold with incorrect cannabinoid values, where the total labelled THC and total CBD are lower than the actual total THC and total CBD values in the product.

The printed value of THC was 8.3 mg/g, while the correct amount was 3.7 mg/g. The total labelled THC was 175 mg/g, while the accurate amount was 246 mg/g. The labelled CBD was <0.15 mg/g, while the correct amount should have been <0.1. mg/g. Total CBD was labelled as 0.5 mg/g but should have been 1.4 mg/g 

Health Canada has not received any complaints related to the recall as of publication. Canna Farms Ltd. has currently received one complaint which noted that the label on the product was incorrect. Neither Canna Farms Ltd. nor Health Canada have received any adverse reaction reports for the recalled cannabis product lot.

There were 23 units of recalled product sold from May 31, 2024, to July 23, 2024, under lot number 24AER-DF1. Affected clients can contact Canna Farms directly. 

Canna Farms’ parent company, MediPharm, recently announced it was closing the Canna Farms BC facility and moving operations to Ontario.

Labelling errors remain the most common reason for cannabis product recalls in Canada.

Purileaf recalls Frank CBD Oil 100 due to a labelling error

Written by Staff on . Posted in Cannabis News, Ontario.

Purileaf Brands has recalled one lot of its Frank CBD Oil 100 cannabis extract due to a labelling and packaging error. 

The products were distributed in Ontario.

The recall was due to the product label on the secondary packaging having an incorrect brand name and incorrect cannabinoid values. 

Health Canada says the labelled CBD, total CBD, and total CBD per activation values are lower than the actual CBD, total CBD, and total CBD per activation values, but the primary label on the bottle is correct.

The printed name on the label is Frank CBD – CBD Oil 20, while it should have been Frank CBD – CBD Oil 100. 

The printed amount of CBD on the label is 20 mg/g and total CBD as 20 mg/g while the actual name and value should have been labelled as CBD: 100 mg/g and Total CBD: 100 mg/g.

This product was sold through the Ontario Cannabis Store and authorized retailers in Ontario.

To date, neither Purileaf Brands Corporation or Health Canada have received any complaints or adverse reaction reports related to the recalled lot.

There were  108 units of recalled product sold from June 24 to July 12, 2024. Consumers can return the recalled products to the store where they purchased them from.